Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis
- PMID: 20197326
- PMCID: PMC2831170
- DOI: 10.1136/bmj.c845
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis
Abstract
Objectives: To determine if the length of interval between breast conserving surgery and start of radiotherapy affects local recurrence and to identify factors that might be associated with delay in older women with breast cancer.
Design: Retrospective cohort analysis with Cox proportional hazards models to study the association between time to radiotherapy and local recurrence, and propensity score and instrumental variable analyses to confirm findings. Logistic regression investigated factors associated with later start of radiotherapy.
Setting: Linked database (Surveillance, Epidemiology, and End Results Program-Medicare) in the United States
Participants: 18 050 women aged over 65 with stage 0-II breast cancer diagnosed in 1991-2002 who received breast conserving surgery and radiotherapy but not chemotherapy.
Main outcome measure: Local recurrence.
Results: Median time from surgery to start of radiotherapy was 34 days, with 29.9% (n=5389) of women starting radiotherapy after six weeks. Just over 4% (n=734) of the cohort experienced a local recurrence. After adjustment for clinical and sociodemographic factors, intervals over six weeks were associated with increased likelihood of local recurrence (hazard ratio 1.19, 95% confidence interval 1.01 to 1.39, P=0.033). When the interval was modelled continuously (assessing accumulation of risk by day), the effect was statistically stronger (hazard ratio 1.005 per day, 1.002 to 1.008, P=0.004). Propensity score and instrumental variable analysis confirmed these findings. Instrumental variable analysis showed that intervals over six weeks were associated with a 0.96% increase in recurrence at five years (P=0.026). In multivariable analysis, starting radiotherapy after six weeks was significantly associated with positive nodes, comorbidity, history of low income, Hispanic ethnicity, non-white race, later year of diagnosis, and residence outside the southern states of the US.
Conclusions: There is a continuous relation between the interval from breast conserving surgery to radiotherapy and local recurrence in older women with breast cancer, suggesting that starting radiotherapy as soon as possible could minimise the risk of local recurrence. There are considerable disparities in time to starting radiotherapy after breast conserving surgery. Regions of the US known to have increased rates of breast conserving surgery had longer intervals before radiotherapy, suggesting limitations in capacity. Given the known negative impact of local recurrence on survival, mechanisms to ameliorate disparities and policies regarding waiting times for treatment might be warranted.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Waiting times for radiotherapy after breast cancer.BMJ. 2010 Mar 2;340:c1007. doi: 10.1136/bmj.c1007. BMJ. 2010. PMID: 20197324 No abstract available.
Similar articles
-
Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.Clin Breast Cancer. 2011 Apr;11(2):114-20. doi: 10.1016/j.clbc.2011.03.004. Epub 2011 Apr 11. Clin Breast Cancer. 2011. PMID: 21569997
-
Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):869-74. doi: 10.1016/s0360-3016(97)00922-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531372
-
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.JAMA Oncol. 2020 Apr 1;6(4):505-511. doi: 10.1001/jamaoncol.2019.5559. JAMA Oncol. 2020. PMID: 31917424 Free PMC article. Clinical Trial.
-
When may adjuvant radiotherapy be avoided in operable breast cancer?Clin Oncol (R Coll Radiol). 2006 Apr;18(3):191-9. doi: 10.1016/j.clon.2005.11.005. Clin Oncol (R Coll Radiol). 2006. PMID: 16605050 Review.
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.Lancet. 2005 Dec 17;366(9503):2087-106. doi: 10.1016/S0140-6736(05)67887-7. Lancet. 2005. PMID: 16360786 Review.
Cited by
-
Innovative Standards in Oncoplastic Breast Conserving Surgery: From Radical Mastectomy to Extreme Oncoplasty.Breast Care (Basel). 2021 Dec;16(6):559-573. doi: 10.1159/000518992. Epub 2021 Sep 16. Breast Care (Basel). 2021. PMID: 35087359 Free PMC article. Review.
-
Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population.Adv Radiat Oncol. 2022 Jul 19;7(6):101017. doi: 10.1016/j.adro.2022.101017. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420195 Free PMC article.
-
Waiting time for radiation therapy after breast-conserving surgery in early breast cancer: a retrospective analysis of local relapse and distant metastases in 615 patients.Eur J Med Res. 2016 Aug 11;21(1):32. doi: 10.1186/s40001-016-0226-9. Eur J Med Res. 2016. PMID: 27514645 Free PMC article.
-
Reduced racial disparity in receipt of optimal locoregional treatment for women with early-stage breast cancer.PLoS One. 2023 Sep 1;18(9):e0291025. doi: 10.1371/journal.pone.0291025. eCollection 2023. PLoS One. 2023. PMID: 37656742 Free PMC article.
-
Cardiovascular disease in women with breast cancer - a nationwide cohort study.BMC Cancer. 2021 Sep 18;21(1):1040. doi: 10.1186/s12885-021-08716-5. BMC Cancer. 2021. PMID: 34537007 Free PMC article.
References
-
- Johnston GM, MacGarvie VL, Elliott D, Dewar RA, MacIntyre MM, Nolan MC. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000. Clin Invest Med 2004;27:142-56. - PubMed
-
- Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994;30:221-8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical